Wrong again. A trial discontinued by the company can’t meet the primary endpoints. I guarantee you Uncle Leo will never claim the K trial met the primary endpoints.
The real insult to injury here is that Menon gave away millions of shares to Aruda for a compound that is worth nothing. And he did this privately without making Aspire prove anything. And Leo the great businessman signed off.